Solid Biosciences (SLDB) Change in Accured Expenses (2017 - 2024)
Historic Change in Accured Expenses for Solid Biosciences (SLDB) over the last 8 years, with Q4 2024 value amounting to $1.6 million.
- Solid Biosciences' Change in Accured Expenses rose 19872.34% to $1.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.8 million, marking a year-over-year increase of 16840.82%. This contributed to the annual value of $4.8 million for FY2024, which is 16840.82% up from last year.
- According to the latest figures from Q4 2024, Solid Biosciences' Change in Accured Expenses is $1.6 million, which was up 19872.34% from $3.3 million recorded in Q3 2024.
- Solid Biosciences' 5-year Change in Accured Expenses high stood at $8.7 million for Q2 2022, and its period low was -$5.0 million during Q3 2022.
- Over the past 5 years, Solid Biosciences' median Change in Accured Expenses value was -$341000.0 (recorded in 2021), while the average stood at $10950.0.
- The largest annual percentage gain for Solid Biosciences' Change in Accured Expenses in the last 5 years was 151500.82% (2022), contrasted with its biggest fall of 154437.09% (2022).
- Quarter analysis of 5 years shows Solid Biosciences' Change in Accured Expenses stood at $887000.0 in 2020, then soared by 190.42% to $2.6 million in 2021, then decreased by 0.27% to $2.6 million in 2022, then crashed by 164.03% to -$1.6 million in 2023, then soared by 198.72% to $1.6 million in 2024.
- Its Change in Accured Expenses was $1.6 million in Q4 2024, compared to $3.3 million in Q3 2024 and -$380000.0 in Q2 2024.